Comparing the effects of dietary sugars on cognitive performance and reaction time: A randomized, placebo- controlled and double-blind experimental trial.
Hacı Ömer YılmazÇağdaş Salih MeriçNurcan Yabancı AyhanPublished in: Applied neuropsychology. Adult (2023)
The aim of the study was to compare the effects of acute intake dietary sugars on cognitive performance and reaction time. This study was, randomized, placebo-controlled, double-blind experimental design, conducted with 75 healthy adults. At the beginning of the study, the participants (36 male, 39 female; 21.6 ± 1.3 years of age; body mass index: 21.59 ± 1.94 kg/m 2 ) were randomly divided into equal five groups (n:15) (glucose (10 g), fructose (10 g), sucrose (10 g), saccharin (0.24 g), placebo), and received dietary sugars dissolved in 200 mL of water. Cognitive performance was determined with Cancelation Test, and the Simple Response Time and Ruler Drop Tests were used in order to response and reaction time of participants, respectively. General score of cognitive performance (0.93 ± 0.1), reaction (295 ± 20 ms), and response (204 ms) were highest in glucose and lowest in placebo (0.63 ± 0.1; 368 ± 22 ms; 251 ms, respectively) ( p < .001). Saccharin groups had a higher reaction (312 ± 22 ms) and response (216 ms) time score compared to consumed fructose (316 ± 39; 227 ms), sucrose (354 ± 26; 246 ms), and placebo (368 ± 22; 251 ms) groups, respectively ( p < .001). These findings show that differences in the absorption pattern and sweetness levels of sugar types may have different effects on cognitive performance and reaction time.
Keyphrases
- double blind
- placebo controlled
- ms ms
- phase iii
- mass spectrometry
- multiple sclerosis
- phase ii
- clinical trial
- study protocol
- body mass index
- open label
- phase ii study
- physical activity
- intensive care unit
- squamous cell carcinoma
- high performance liquid chromatography
- blood pressure
- electron transfer
- liquid chromatography tandem mass spectrometry
- blood glucose
- liquid chromatography
- hepatitis b virus
- weight gain
- liver failure